Drug Name: Semaglutide Manufacturer: Novo Nordisk Type: GLP-1 agonist Brand Names: Ozempic = Type 2 Diabetes, weekly injection (approved December, 2017) Rebylsus = Type 2 Diabetes, daily pill (approved September, 2019) Wegovy = Weight Loss, weekly injection (approved June, 2021) Drug Name: Tirzepatide Manufacturer: Eli Lilly Type: GLP-1/GIP co-agonist Brand Names: Mounjaro = Type 2 Diabetes, weekly injection (approved May, 2022) Zepbound = Weight Loss Application, weekly injection (approved November, 2023) (No pill form exists as of this writing) The short story is that both drugs were originally introduced as effective Type 2 Diabetes medications
Retatrutide: The Triple GLP-1/GIP/Glucagon Agonist Retatrutide adds a third receptor glucagon to the dual-agonist approach
Though there is no harm in pairing them, you should be aware of the increased risk of skin sensitisation
Each serving provides 12 grams of protein from a blend of hydrolyzed collagen and whey protein isolate, with just 1 to 3 grams of carbs and 60 calories, plus 100 percent of the daily recommended dose of vitamin C